Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysisCéline Eldani, E. Gérard, Claire Rigothier et al.|Frontiers in Oncology|2024Cited by 14
Esophageal Achalasia Induced by Ipilimumab and Nivolumab Combination: A Rare Neurological Manifestation of Immune-related Autonomic NeuropathyGaëlle Montes, S. Prey, Fanny Duval et al.|Journal of Immunotherapy|2021Cited by 8